Management Program Nonseminoma
40-45 % of patients with testicular cancer are diagnosed with nonseminoma, of these 55-60 % will only have disease in the testicle while 40-45 % will have metastatic disease to lymphnodes, the lungs or other organs. Even with metastatic disease most patients are cured.
Patients with metastatic nonseminoma are treated with a minimum of three courses of chemotherapy. Some patients need more intense treatment with additional drugs, or by using high dose chemotherapy.
If there are visible tumour lesions remaining after chemotherapy, most patients will need surgery. The most common site for this kind of surgery is in the abdomen, or the lungs